Posttransplant lymphoproliferative disorders are typically of B cell origin
, whereas T cell lymphomas have been rarely documented. We present a case o
f a non-Hodgkin's T cell lymphoma involving the intestinal graft of a multi
visceral transplant patient. The patient was a 7-year-old girl who underwen
t at age 5 a multivisceral transplant secondary to short gut syndrome. Base
line immunosuppressive therapy consisted of FK506, methylprednisone, and my
cophenolate mofetil, At 2 years posttransplant she presented with fever, di
arrhea, nausea, and vomiting. Multiple endoscopic biopsies revealed a sever
e intensity, diffuse and focally nodular lymphocytic infiltrate composed pr
edominantly of small, monomorphic lymphoid cells with scattered plasma cell
s and abundant eosinophils, Immunohistochemically, the majority of the lymp
hoid cells expressed the pan T cell marker CD3, Southern blot analysis reve
aled rearrangement of the T cell receptor beta chain gene, with germline co
nfiguration of the heavy immunoglobulin chain gene, confirming a clonal T c
ell genotype. In situ hybridization for Epstein Barr virus revealed rare po
sitive lymphoid cells, that were negative with CD3 by immunohistochemical s
taining. A detailed clinico-radiological work-up revealed no other sites of
involvement by the lymphomatous process. After the diagnosis of posttransp
lant lymphoproliferative disorder, immunosuppression was reduced with a sub
sequent partial improvement in the endoscopic appearance of the graft and a
focal decrease in the lymphocytic infiltrate seen in the follow-up biopsie
s. Repeat gene rearrangement studies demonstrated germline configuration of
both the T cell receptor beta chain gene and the heavy chain immunoglobuli
n, gene. To our knowledge, this represents the first description of a T cel
l lymphoma affecting the intestinal allograft of a multivisceral transplant
patient.